The majority of patients (85%) with osteogenesis imperfecta have an autosomal dominant mutation in genes responsible for the synthesis of type I collagen, specifically COL1A1 and COL1A2. Two primary mutations in these genes are linked to either structural or quantitative defects in the production or processing of type I collagen. This evidence concerns the gene COL1A2 and osteogenesis imperfecta.